Un bref aperçu de SEC, un régime potentiel d’épargne de la dexaméthasone pour le glioblastome: spironolactone, écallantide, clotrimazole

Translated title of the contribution: Short review of SEC, a potential dexamethasone-sparing regimen for glioblastoma: Spironolactone, ecallantide, clotrimazole

R. E. Kast, T. C. Burns, M. E. Halatsch

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Short review of SEC, a potential dexamethasone-sparing regimen for glioblastoma: Spironolactone, ecallantide, clotrimazole'. Together they form a unique fingerprint.

Medicine & Life Sciences